We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The eSensor Respiratory Viral Panel is designed to be a fast, easy-to-use molecular diagnostic test to provide accurate results while requiring less technologist time.

"The submission to the FDA of our eSensor Respiratory Viral Panel is an important step in GenMark's continued commitment to providing our customers with high quality in-vitro diagnostic molecular tests for use with our award winning eSensor XT-8 system," commented Hany Massarany, President and CEO of GenMark Diagnostics.